Annual Retained Earnings
-$388.00 M
-$17.21 M-4.64%
December 31, 2022
Summary
- As of February 8, 2025, NAVB annual retained earnings is -$388.00 million, with the most recent change of -$17.21 million (-4.64%) on December 31, 2022.
- During the last 3 years, NAVB annual retained earnings has fallen by -$40.33 million (-11.60%).
- NAVB annual retained earnings is now -2691.39% below its all-time high of -$13.90 million, reached on December 31, 1992.
Performance
NAVB Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$385.91 M
-$2.26 M-0.59%
September 30, 2023
Summary
- As of February 8, 2025, NAVB quarterly retained earnings is -$385.91 million, with the most recent change of -$2.26 million (-0.59%) on September 30, 2023.
- Over the past year, NAVB quarterly retained earnings has dropped by -$2.26 million (-0.59%).
- NAVB quarterly retained earnings is now -2868.53% below its all-time high of -$13.00 million, reached on September 30, 1992.
Performance
NAVB Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
NAVB Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.6% | -0.6% |
| 3 y3 years | -11.6% | -0.6% |
| 5 y5 years | -21.3% | -0.6% |
NAVB Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -4.6% | at low | -4.1% | +0.9% |
| 5 y | 5-year | -11.6% | at low | -11.0% | +0.9% |
| alltime | all time | -2691.4% | +1.7% | -2868.5% | +2.3% |
Navidea Biopharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | -$385.91 M(+0.6%) |
| Jun 2023 | - | -$383.65 M(-1.5%) |
| Mar 2023 | - | -$389.48 M(+0.4%) |
| Dec 2022 | -$388.00 M(+4.6%) | -$388.00 M(+0.9%) |
| Sep 2022 | - | -$384.52 M(+2.1%) |
| Jun 2022 | - | -$376.77 M(+0.8%) |
| Mar 2022 | - | -$373.77 M(+0.8%) |
| Dec 2021 | -$370.79 M(+3.3%) | -$370.79 M(+1.0%) |
| Sep 2021 | - | -$367.14 M(+0.7%) |
| Jun 2021 | - | -$364.70 M(+0.7%) |
| Mar 2021 | - | -$362.02 M(+0.8%) |
| Dec 2020 | -$359.06 M(+3.3%) | -$359.06 M(+0.8%) |
| Sep 2020 | - | -$356.05 M(+0.9%) |
| Jun 2020 | - | -$352.75 M(+0.7%) |
| Mar 2020 | - | -$350.34 M(+0.8%) |
| Dec 2019 | -$347.67 M(+3.3%) | -$347.67 M(+0.8%) |
| Sep 2019 | - | -$344.90 M(+0.9%) |
| Jun 2019 | - | -$341.83 M(+0.8%) |
| Mar 2019 | - | -$339.15 M(+0.7%) |
| Dec 2018 | -$336.72 M(+5.3%) | -$336.72 M(+0.9%) |
| Sep 2018 | - | -$333.56 M(+1.2%) |
| Jun 2018 | - | -$329.74 M(+0.7%) |
| Mar 2018 | - | -$327.35 M(+2.3%) |
| Dec 2017 | -$319.91 M(-19.0%) | -$319.91 M(+1.3%) |
| Sep 2017 | - | -$315.85 M(+0.4%) |
| Jun 2017 | - | -$314.46 M(+1.7%) |
| Mar 2017 | - | -$309.27 M(-21.7%) |
| Dec 2016 | -$394.86 M(+3.8%) | -$394.86 M(+1.0%) |
| Sep 2016 | - | -$390.97 M(+0.0%) |
| Jun 2016 | - | -$390.91 M(+1.7%) |
| Mar 2016 | - | -$384.23 M(+1.0%) |
| Dec 2015 | -$380.55 M(+7.8%) | -$380.55 M(+0.7%) |
| Sep 2015 | - | -$378.04 M(+2.2%) |
| Jun 2015 | - | -$369.97 M(+2.7%) |
| Mar 2015 | - | -$360.28 M(+2.1%) |
| Dec 2014 | -$352.98 M(+11.3%) | -$352.98 M(+2.0%) |
| Sep 2014 | - | -$346.12 M(+2.0%) |
| Jun 2014 | - | -$339.22 M(+3.1%) |
| Mar 2014 | - | -$329.00 M(+3.7%) |
| Dec 2013 | -$317.26 M(+15.6%) | -$317.26 M(+4.5%) |
| Sep 2013 | - | -$303.51 M(+3.9%) |
| Jun 2013 | - | -$292.20 M(+3.7%) |
| Mar 2013 | - | -$281.90 M(+2.7%) |
| Dec 2012 | -$274.56 M(+11.9%) | -$274.56 M(+2.7%) |
| Sep 2012 | - | -$267.35 M(+3.5%) |
| Jun 2012 | - | -$258.23 M(+2.3%) |
| Mar 2012 | - | -$252.37 M(+2.9%) |
| Dec 2011 | -$245.36 M(-2.2%) | -$245.36 M(+3.2%) |
| Sep 2011 | - | -$237.72 M(-7.7%) |
| Jun 2011 | - | -$257.53 M(+0.9%) |
| Mar 2011 | - | -$255.32 M(+1.8%) |
| Dec 2010 | -$250.87 M(+30.2%) | -$250.87 M(+0.8%) |
| Sep 2010 | - | -$248.79 M(+1.0%) |
| Jun 2010 | - | -$246.39 M(+26.2%) |
| Mar 2010 | - | -$195.22 M(+1.3%) |
| Dec 2009 | -$192.70 M(+29.5%) | -$192.70 M(+0.2%) |
| Sep 2009 | - | -$192.34 M(+15.0%) |
| Jun 2009 | - | -$167.28 M(+10.0%) |
| Mar 2009 | - | -$152.10 M(+2.2%) |
| Dec 2008 | -$148.84 M | -$148.84 M(+2.9%) |
| Sep 2008 | - | -$144.71 M(+1.3%) |
| Jun 2008 | - | -$142.82 M(+0.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | -$141.80 M(+0.7%) |
| Dec 2007 | -$140.78 M(+3.7%) | -$140.78 M(+1.4%) |
| Sep 2007 | - | -$138.88 M(+0.7%) |
| Jun 2007 | - | -$137.93 M(+0.8%) |
| Mar 2007 | - | -$136.80 M(+0.8%) |
| Dec 2006 | -$135.69 M(+3.6%) | -$135.69 M(+1.0%) |
| Sep 2006 | - | -$134.39 M(+1.2%) |
| Jun 2006 | - | -$132.74 M(+0.7%) |
| Mar 2006 | - | -$131.87 M(+0.7%) |
| Dec 2005 | -$130.95 M(+3.9%) | -$130.95 M(+1.0%) |
| Sep 2005 | - | -$129.65 M(+1.0%) |
| Jun 2005 | - | -$128.37 M(+1.1%) |
| Mar 2005 | - | -$127.02 M(+0.8%) |
| Dec 2004 | -$126.02 M(+2.9%) | -$126.02 M(+1.8%) |
| Sep 2004 | - | -$123.73 M(+0.2%) |
| Jun 2004 | - | -$123.50 M(+0.3%) |
| Mar 2004 | - | -$123.07 M(+0.5%) |
| Dec 2003 | -$122.48 M(+1.5%) | -$122.48 M(+0.5%) |
| Sep 2003 | - | -$121.90 M(+0.5%) |
| Jun 2003 | - | -$121.24 M(+0.1%) |
| Mar 2003 | - | -$121.16 M(+0.4%) |
| Dec 2002 | -$120.68 M(+2.5%) | -$120.68 M(+0.1%) |
| Sep 2002 | - | -$120.51 M(+0.9%) |
| Jun 2002 | - | -$119.43 M(+0.7%) |
| Mar 2002 | - | -$118.56 M(+0.7%) |
| Dec 2001 | -$117.71 M(-0.0%) | -$117.71 M(+0.6%) |
| Sep 2001 | - | -$117.07 M(-0.3%) |
| Jun 2001 | - | -$117.47 M(-0.2%) |
| Mar 2001 | - | -$117.65 M(-0.1%) |
| Dec 2000 | -$117.73 M(-1.5%) | -$117.73 M(-0.6%) |
| Sep 2000 | - | -$118.45 M(-0.4%) |
| Jun 2000 | - | -$118.96 M(-0.5%) |
| Mar 2000 | - | -$119.60 M(+1.3%) |
| Dec 1999 | -$119.57 M(+3.6%) | - |
| Jun 1999 | - | -$118.10 M(+1.2%) |
| Mar 1999 | - | -$116.70 M(+1.1%) |
| Dec 1998 | -$115.40 M(+32.1%) | -$115.40 M(+9.6%) |
| Sep 1998 | - | -$105.30 M(+5.6%) |
| Jun 1998 | - | -$99.70 M(+5.6%) |
| Mar 1998 | - | -$94.40 M(+8.1%) |
| Dec 1997 | -$87.36 M(+36.3%) | -$87.36 M(+7.2%) |
| Sep 1997 | - | -$81.50 M(+7.1%) |
| Jun 1997 | - | -$76.10 M(+10.6%) |
| Mar 1997 | - | -$68.80 M(+7.3%) |
| Dec 1996 | -$64.10 M(+48.7%) | -$64.10 M(+15.9%) |
| Sep 1996 | - | -$55.30 M(+8.2%) |
| Jun 1996 | - | -$51.10 M(+9.4%) |
| Mar 1996 | - | -$46.70 M(+8.4%) |
| Dec 1995 | -$43.10 M(0.0%) | -$43.10 M(+8.0%) |
| Sep 1995 | - | -$39.90 M(+6.7%) |
| Jun 1995 | - | -$37.40 M(+7.2%) |
| Mar 1995 | - | -$34.90 M(-19.0%) |
| Dec 1994 | -$43.10 M(+97.7%) | -$43.10 M(+44.6%) |
| Sep 1994 | - | -$29.80 M(+12.9%) |
| Jun 1994 | - | -$26.40 M(+8.2%) |
| Mar 1994 | - | -$24.40 M(+11.9%) |
| Dec 1993 | -$21.80 M(+56.8%) | -$21.80 M(+13.0%) |
| Sep 1993 | - | -$19.30 M(+12.2%) |
| Jun 1993 | - | -$17.20 M(+13.2%) |
| Mar 1993 | - | -$15.20 M(+9.4%) |
| Dec 1992 | -$13.90 M | -$13.90 M(+6.9%) |
| Sep 1992 | - | -$13.00 M |
FAQ
- What is Navidea Biopharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals annual retained earnings year-on-year change?
- What is Navidea Biopharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals quarterly retained earnings year-on-year change?
What is Navidea Biopharmaceuticals annual retained earnings?
The current annual retained earnings of NAVB is -$388.00 M
What is the all time high annual retained earnings for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high annual retained earnings is -$13.90 M
What is Navidea Biopharmaceuticals annual retained earnings year-on-year change?
Over the past year, NAVB annual retained earnings has changed by -$17.21 M (-4.64%)
What is Navidea Biopharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of NAVB is -$385.91 M
What is the all time high quarterly retained earnings for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high quarterly retained earnings is -$13.00 M
What is Navidea Biopharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, NAVB quarterly retained earnings has changed by -$2.26 M (-0.59%)